Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir 5% gel versus acyclovir 5% cream for herpes labialis
2007-000182-38Phase 3Terminated
- Sponsor
- Mipharm
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of aciclovir in herpes labialis (2 arms), sponsored by Mipharm. Primary endpoint: Clinical efficacy at day 10. Started Jun 2007; status: terminated.
02
Drugs
aciclovir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on 2007-000182-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000182-38.